Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)

NCT03086200 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03086200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03086200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Completed
Start date
June 23, 2017
Completion date
December 18, 2020
Enrollment
263 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv seronegativity, patient adherence